Newly Synthesized Radical-Containing Nanoparticles Enhance Neuroprotection After Cerebral Ischemia-Reperfusion Injury
Authors:
- Kensuke SuzukiKSKensuke Suzuki
- Yukio NagasakiYNYukio Nagasaki
- Toru YoshitomiTYToru Yoshitomi
- Kazuko TohKTKazuko Toh
- Hideo TsurushimaHTHideo Tsurushima
- Aki HirayamaAHAki Hirayama
- Akira MatsumuraAMAkira Matsumura
- 1 May 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 68 (5) , 1418-1426
Abstract
Antioxidant nitroxyl radicals such as 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) have been investigated for their ability to scavenge free radicals produced by ischemia-reperfusion injury. However, the short in vivo half-life and toxicity of TEMPO have limited their clinical application. We developed a core-shell-type nanoparticle, termed a radical-containing nanoparticle (RNP), to deliver nitroxyl radicals with prolonged in vivo half-life and pH-sensitivity. We evaluated the ability of RNP to deliver TEMPO radicals to the ischemic brain and scavenge free radicals in cerebral ischemia-reperfusion injury using rats. When RNPs were administrated to middle cerebral artery occlusion rats, the delivery and clearance of RNPs were detected using electron paramagnetic resonance (EPR) assay. The production of superoxide anion in neuronal cells was observed with dihydroethidium staining. The treatment effects were evaluated by measuring the cerebral infarction volumes, lipid peroxidation and protein oxidation, and neurological symptom scoring. The TEMPO radicals contained in RNPs were detected for 6 hours after intravenous administration as a triplet EPR signal in the ischemic brain, and RNPs significantly reduced the production of superoxide anion in neuronal cells compared with saline and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyls (TEMPOL). The infarction volumes of rats treated by RNPs were significantly lower than those of rats treated by saline, micelles, and TEMPOL. In addition, RNP treatment suppressed lipid peroxidation and protein oxidation, and limited the adverse effects of TEMPO radicals such as hypotension. RNPs could be a promising neuroprotective agent with their enhanced ability to scavenge free radicals and reduced toxicity.Keywords
This publication has 21 references indexed in Scilit:
- Tissue plasminogen activator-induced reperfusion injury after stroke revisited.Circulation, 2007
- The chemistry and biology of nitroxide compoundsFree Radical Biology and Medicine, 2007
- Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsThe Lancet, 2004
- Stable nitroxide Tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemiaBrain Research, 2003
- The Nitroxide Antioxidant Tempol Is Cerebroprotective against Focal Cerebral Ischemia in Spontaneously Hypertensive RatsExperimental Neurology, 2002
- Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemiaJournal of Neurosurgery, 2000
- Hemodynamic effect of the nitroxide superoxide dismutase mimicsFree Radical Biology and Medicine, 1999
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia.Proceedings of the National Academy of Sciences, 1995
- Cytotoxicity of commonly used nitroxide radical spin probesLife Sciences, 1987